- NYT’s David Brooks: Obama has ‘manhood problem’ in Middle East
- Ted Cruz thanks Obama for denying visas to terrorists
- Survivors recall chaos, fear in Everest avalanche
- General Mills apologizes for ‘right to sue’ confusion, reverses policy
- Dealer wanted in U.S. for art fraud nabbed in Spain
- Easter morning delivery for space station
- Boxer Rubin ‘Hurricane’ Carter dies at 76
- Probe could complicate Rick Perry’s prospects
- Ukraine, Russia trade blame for eastern shootout
- Obamas head to church on Easter morning
7 Ohio oncologists put on probation in drug case
CLEVELAND (AP) - Seven cancer specialists in northern Ohio have been put on probation based on their guilty pleas to importing unapproved cancer drugs from Canada, the U.S. government said Wednesday.
The government said the seven must pay a total of $2.6 million in fines, penalties and restitution to Medicare.
The doctors pleaded guilty to violating the Food, Drug and Cosmetic Act. The charges were filed last August, and the doctors were sentenced over the past four months.
The seventh defendant, Dr. Hassan Tahsildar, 55, of nearby Euclid, was put on probation for a year on Tuesday by a magistrate judge in U.S. District Court. He was ordered to pay $179,316 in fines and restitution.
His attorney, Anthony Vegh, said Wednesday the case was never about the efficacy of the drugs prescribed by Tahsildar.
“He has always provided his patients the highest quality of care and continues to do so today,” Vegh said.
Colleagues who have practiced with Tahsildar in Green Bay, Wis., wrote character letters to the court to express their respect for him and his work. One said he believed the drug importing was meant to help his patients, not benefit himself.
A pre-sentence report for a co-defendant, Dr. David Fishman, 62, also of Euclid, said he began using lower-cost but identical drugs from Canada after Medicare cut drug reimbursements to 85 percent of the average cost for office-based oncologists.
A single chemotherapy treatment can cost $10,000, so the reimbursement created a financial burden, Fishman’s attorney told the court.
All seven drug importing cases were handled through a criminal information filing with the court, indicating they had cooperated with investigators.
“These doctors used drugs that had not been approved by the FDA,” U.S. Attorney Steven Dettelbach said in announcing the wrap-up of the cases.
The doctors were charged with importing unapproved drugs, including Zometa, Kytril, Taxotere, Gemzar, Eloxatin and others. The drugs are used to treat a variety of cancer types or side effects of cancer chemotherapy.
A drug may be considered misbranded even if it is identical in composition to an approved drug. The misbranding wasn’t specified.
The misbranding rule applies even if the drug was produced by the same manufacturer and in the same facility as the approved version.
TWT Video Picks
Women losing coverage under Obamacare, too
- Former Ranger breaks silence on Pat Tillman death: I may have killed him
- Scalia to students on high taxes: At a certain point, 'perhaps you should revolt'
- Special Forces' suicide rates hit record levels casualties of 'hard combat'
- EXCLUSIVE: FBI blocked in corruption probe involving Sens. Reid, Lee
- Tactical advantage: Russian military shows off impressive new gear
- USAID documents cite Hillary Clinton in chaos of Afghan aid
- Feds approve powdered alcohol; 'Palcohol' available later this year
- U.S. Navy to turn seawater into jet fuel
- Army goes to war with National Guard, seizes Apache attack helicopters
- Yelp.com's ethics questioned
Top 10 handguns in the U.S.